OncologyCE
LECTURECME

Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective

Author(s)/Faculty: Eric S. Nadler, MD, MPP; Lisa Ovesen, FNP-BC; Luis A. Pineiro, MD; Wolfram Samlowski, MD; Nicholas J. Vogelzang, MD, FASCO, FACP
Release Date: 1/16/2018Expiration Date: 1/15/2019
Credit Type: CMENumber of Credits: 0.5
Content Type: LectureProvider:
The integration of immunotherapies into management strategies for the treatment of numerous hard-to-treat malignancies has provided significant improvements in clinical outcomes. Along with clinical benefits, the rapid development and approval of immunotherapies for the treatment of cancer has also provided many challenges, especially in areas of patient selection, therapy response monitoring, as well as in the identification and management of immune-related adverse events. In this CME activity, an expert panel of oncologists discuss persisting clinical challenges in the utilization of immune checkpoint inhibitors in treatment strategies for cancer, including the value of molecular testing for PD-L1, the future of combination therapy, defining optimal treatment durations, as well as the benefits and limitations of current cost models.